AngioDynamics

AngioDynamics is a publicly traded medical technology company founded in 1988 and became independent in 2004. The company specializes in designing, manufacturing, and selling minimally invasive medical devices used primarily in vascular access, surgery, peripheral vascular disease, and oncology treatments. Its product portfolio includes diagnostic and therapeutic catheters, vascular access devices, and various ablation technologies. Notable offerings include the NanoKnife system, AngioVac vascular removal system, and Auryon laser atherectomy platform. AngioDynamics has expanded its range through strategic acquisitions, enhancing its market presence and product diversity. Headquartered in Queensbury, New York, AngioDynamics serves a wide customer base, including hospitals, interventional radiologists, oncologists, vascular surgeons, and dialysis centers worldwide. The company is committed to improving patient outcomes by providing effective, less invasive therapeutic options.

• Employees 750
• Founded 1988
• Annual Revenue $292498000
• Total Funding $271450000